Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 7, 2017; 23(41): 7425-7432
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7425
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7425
Table 2 Correlation of the GPR, APRI, and FIB-4 (mean ± SD) with the liver function severity classification
Parameter | n | GPR | APRI | FIB-4 |
Liver function grade mild | ||||
Mild | 244 | 0.50 ± 0.92 | 30.71 ± 76.73 | 68.39 ± 126.12 |
r | 0.213 | 0.091 | 0.219 | |
P | < 0.01 | < 0.01 | < 0.01 | |
Moderate | 57 | 1.57 ± 3.59 | 101.20 ± 202.09 | 511.23 ± 1234.61 |
r | 0.11 | 0.16 | 0.191 | |
P | < 0.01 | < 0.01 | < 0.01 | |
Severe | 80 | 0.84 ± 1.74 | 145.90 ± 192.51 | 1417.54 ± 2544.58 |
r | 0.016 | 0.563 | 0.720 | |
P | < 0.01 | < 0.01 | < 0.01 |
- Citation: Hu YC, Liu H, Liu XY, Ma LN, Guan YH, Luo X, Ding XC. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B. World J Gastroenterol 2017; 23(41): 7425-7432
- URL: https://www.wjgnet.com/1007-9327/full/v23/i41/7425.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i41.7425